Lauren Santye, Assistant Editor

It was previously believed that HIV-related brain inflammation may prevent Alzheimer’s disease.

Study offers hope to women for whom infertility treatments were unsuccessful.

Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.

ASCL1 protein critical in the development of small cell lung cancer.

A look at the lighter side of pharmacy and the rigors of patient management.

Vyndaqel in development for mild transthyretin familial amyloid polyneuropathy (TTR-FAP).

Olanzapine found to reduce chemotherapy-induced nausea and vomiting in cancer patients.

Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.

Treatment with Truvada highly effective in reducing the risk of HIV.

Top news of the day from across the health care landscape.

Certain mutations influence risk of drug resistance across several cancer types.

Zepatier is a fixed-dose combination therapy of elbasvir and grazoprevir for chronic hepatitis C.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to help detect and fight tumor cells.

Opdivo monotherapy for first-line lung cancer unable to meet primary endpoint of progression-free survival.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to help detect and fight tumor cells.

Experimental drug showed strong efficacy in numerous cellular animal models of amyotrophic lateral sclerosis (ALS).

Ovarian cancer among the highest death rates for all gynecological cancers.

Top news of the day from across the health care landscape.

Damage associated with leukemia occurs in regions where DNA is transcribed actively.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School Clinical Pharmacy Services, discusses the components of successful medication therapy management.

The relevancy of randomized controlled trials of experimental drugs for multiple sclerosis in standard practice called into question.

Drugs that target the signal-peptide peptidase enzyme may halt HCV development.

Lowering antioxidant levels shows promise treating pancreatic cancer.

Study highlights the importance of sunscreen and other protective measures against skin cancer.

Top news of the day from across the health care landscape.

Researchers believe prostate cancer has become more aggressive.

Researchers seek to eliminate HIV reservoirs with antiretroviral therapy.

Hormones in body fat provide bridge between breast cancer and obesity.

Pokémon Go may help reduce burdens of obesity and diabetes.

Adcetris is an antibody-drug conjugate that may improve treatment of cutaneous T cell lymphoma.